Paul J Davis

15PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Art history, theory and criticism not elsewhere classifiedMolecular targetsInnate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 17, 2024
Additional considerations in cancer cell radioresistance, integrin αvβ3 and thyroid hormones.

Gennadi V Glinsky, Aleck Hercbergs, Shaker A Mousa

|Sep 14, 2022
Robert I. Gregerman, MD (1930-2021). An Editorial Reminiscence.

Michael S Katz, Paul J Davis

|Aug 25, 2022
Heteronemin and Tetrac Induce Anti-Proliferation by Blocking EGFR-Mediated Signaling in Colorectal Cancer Cells.

Sukanya Unson, Tung-Cheng Chang, Yung-Ning Yang

|Apr 21, 2022
Effects of Anticancer Agent P-bi-TAT on Gene Expression Link the Integrin Thyroid Hormone Receptor to Expression of Stemness and Energy Metabolism Genes in Cancer Cells.

Gennadi V Glinsky, Kavitha Godugu, Thangirala Sudha

|Nov 15, 2021
Possible Contributions of Nongenomic Actions of Thyroid Hormones to the Vasculopathic Complex of COVID-19 Infection.

Paul J Davis, Hung-Yun Lin, Aleck Hercbergs

|Apr 30, 2021
αvβ3 Integrin Expression and Mitogenic Effects by Thyroid Hormones in Chronic Lymphocytic Leukemia.

Uri Abadi, Avivit Weisz, Dvora Kidron

Pageof 3

Frequent Collaborators

7 joint publications

Shaker A Mousa

3 joint publications

Hung-Yun Lin

2 joint publications

Kelly A Keating

2 joint publications

Aleck Hercbergs